Recent Finacing
Recent Raise
PolyCore Therapeutics is a biopharmaceutical developing PCT-3012, a G protein-biased dopamine D3 receptor agonist undergoing preclinical and IND-enabling studies to treat Parkinson’s motor symptoms and minimize tolerance and dyskinesia.
